secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAge Labs, Inc. (BIOA)
CIK:        0001709941
Form:       8-K
Filed at:   2026-06-12T12:00:16+00:00
Accession:  0001193125-26-268518
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BioAge Labs shareholders elect three Class II directors, ratify KPMG at annual meeting
--------------------------------------------------------------------------------

- Class II directors elected: Patrick Enright (30.1M for, 1.2M withheld), James Healy (25.5M for, 5.8M withheld), Rekha Hemrajani (27.8M for, 3.4M withheld).
- Ratification of KPMG as independent auditor for FY2026 passed with 36.6M for, 1.3K against, 25.1K abstentions.
- Broker non-votes of 5.3M on director election proposals did not affect outcome.
- All directors serve three-year terms expiring at 2029 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1709941/000119312526268518/0001193125-26-268518-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1709941/000119312526268518/bioa-20260610.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-268518

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer